FinanceCity
HealthcareNSE · BSE

Mankind Pharma Limited

MANKIND · ISIN INE634S01028

Share price

₹2,360 -0.84%

Market capitalisation

₹97479 CrClosed

Live from Yahoo Finance. Pulse animates during NSE market hours (9:15–15:30 IST, weekdays).

01 · Key metrics

Market cap

₹97479 Cr

Current price

₹2,360

-0.84% today

52W high

₹2,717

52W low

₹1,910

Stock P/E

51.11

P/B ratio

5.97

02 · Per share & returns

EPS (TTM)

₹46.18

Book value

₹395

ROE

12.45%

ROA

6.11%

Dividend yield

0.08%

Beta

0.47

03 · Financials (TTM)

By the numbers

Revenue

₹14278 Cr

+11.80% YoY

EBITDA

₹3617 Cr

Net profit

₹1913 Cr

+31.70% YoY

Profit margin

13.40%

Operating margin

20.56%

Total debt

₹6312 Cr

Total cash

₹2268 Cr

Debt / equity

0.38x

Current ratio

1.07x

Payout ratio

2.16%

04 · Analyst view

Target price

₹2,653

Upside

+12.42%

Consensus

BUY

Analysts

20

05 · Shareholding pattern

Who owns MANKIND?

  • Promoters

    72.66%

    Founders & promoter group

  • Institutions

    19.68%

    FII + DII

  • Public

    7.66%

    Retail & non-institutional

As of 31 Mar 2026 · Source: NSE corporate filings

06 · Registration & listing

On the record

Symbol
MANKIND
Exchange
NSE · BSE
CIN
ISIN
INE634S01028
BSE code
543904
Sector
Healthcare
Industry
Healthcare
Face value
₹1
Listing date
08 May 2023
Employees
Headquarters
New Delhi, India

07 · About

What is Mankind Pharma Limited?

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory diseases, etc. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, oral contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. In addition, the company engages in the trading and exporting of pharmaceutical and health care products; manufacture of packing materials, ayurvedic products, and consumer goods; real estate, leasing, and hospitality businesses; trading of agricultural products; and provision of IT services. It offers its products under the Manforce, Moxi Kind-Cv, AmLokind-At, Unwanted-Kit, Prega News, Dydroboon, Gudcef, Candi Force, Glimestar-M, Telmikind-Am, Nurokind-Gold, Telmikind-H, Nurokind-Lc, Telmikind, Vomikind, Cefakind, Nurokind Plus-Rf, Gudcef-Cv, Monticope, and Asthakind-Dx brand names. Mankind Pharma Limited was incorporated in 1991 and is based in New Delhi, India.

08 · Common questions

Frequently asked

What is the CIN of Mankind Pharma Limited?+

The Corporate Identity Number for Mankind Pharma Limited is published in the MCA21 corporate master. FinanceCity backfills CIN values during weekly refreshes.

Who are the promoters of Mankind Pharma Limited?+

Promoter holding in MANKIND is approximately 72.66%, as disclosed in the latest published shareholding pattern.

What is the market capitalisation of Mankind Pharma Limited?+

Mankind Pharma Limited (MANKIND) has a market capitalisation of approximately ₹97479 Cr, reflecting the most recent weekly refresh from the BSE scrip master.

09 · Adjacent

Other healthcare listings

Full sector →